Loading...
QLUCF
OTCM
Market cap1mUSD
, Last price  
USD
Name

Qlucore AB (publ)

Chart & performance

D1W1MN
OTCM:QLUCF chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
49.36%
Rev. 5Y
-12.24%
Div Yld LY
—
Div Yld TTM
—
Revenues
7m
-34.00%
14,891,08316,031,00012,943,00014,118,00012,672,00014,369,00010,208,0006,737,000
Net income
-37m
L+77.86%
-633,6071,226,000-6,035,000-11,663,000-15,936,000-15,681,000-20,535,000-36,523,000
CFO
-12m
L-11.94%
01,601,000-1,080,000-6,806,000-8,049,000-16,949,000-14,154,000-12,464,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Lund, Sweden, Qlucore AB (publ) delivers advanced bioinformatics data analysis tools for global application in both scientific research and accurate medical diagnostics. Its product suite includes Qlucore Omics Explorer, an AI-powered bioinformatics software designed for research across various sectors such as life science, biotechnology, food, plant industries, and academia. Additionally, the company offers Qlucore Diagnostics, a specialized software platform for multi-omics companion and precision diagnostics, as well as Qlucore Insights, which facilitates the analysis of clinical data. Qlucore was established in 2007.

Key people

Independent President · since 2018
Anders Bergstrand
Acting Chief Financial Officer · since 2021
Carl-Johan Ivarsson
Chief Executive Officer, Managing Director, Commissioner · since 2023
Commissioner · since 2007
Thoas Fioretos
Commissioner · since 2007
Magnus Fontes
Independent Commissioner · since 2007
Boel Sundvall
Independent Commissioner · since 2019
Johan Thiel
Independent Commissioner · since 2019
IPO date
Nov 05, 2021
Employees
22
Domiciled in
SE
Incorporated in
SE
Headquarters & legal address
Scheelevägen 17
Lund, M 223 70
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2026‑042025‑042024‑042023‑042022‑042021‑042020‑042019‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT